Intercell Executes Multi-Year Contract for Supply of IXIARO to the United States Military

First sales of IXIARO under this military contract expected soon

15-May-2009 - USA

Intercell AG announced that the Company has successfully entered into a multi-year contract with the Defense logistics Agency (DLA), Defense Supply Center of the U.S. Department of Defense to supply IXIARO, a vaccine against Japanese encephalitis (JE). The first sales of IXIARO under this contract are expected in the near future.

This supply contract was negotiated in response to a Request for Proposals (RFP) issued by the DLA in August 2008. The parties were able to move forward to finalize the contract after IXIARO was approved by the Food and Drug Administration on March 30. The major terms of this contract are as follows:

- Exclusive contract for Intercell to supply DLA with all their requirements for JE vaccine

- Five-year contract, with annual options for price modifications

IXIARO was developed by Intercell under an agreement with the Walter Reed Army Institute of Research (WRAIR).

Intercell will directly distribute and market IXIARO to the U.S. military. Novartis Vaccines USA will market and distribute the vaccine to the private market in the U.S.

Other news from the department research and development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

Last viewed contents

Domainex Announces the Appointment of Joanne McCudden As Head of Business Development

GlycoVaxyn and a Harvard University affiliated hospital receive USD 3.4 million NIH grant for Staphylococcus aureus vaccine

Saline water better than soap and water for cleaning wounds, researchers find

Activity of 2 genes will inform anti-cancer drug prescription - Gene expression to guide cancer drug prescription

Activity of 2 genes will inform anti-cancer drug prescription - Gene expression to guide cancer drug prescription

Prion disease detected soon after infection and in surprising place in mouse brains

A type of virus present in the gut microbiota is associated with better cognitive ability in humans, mice and flies - The study finds a greater presence of these viruses in people who eat dairy products in their regular diet

A type of virus present in the gut microbiota is associated with better cognitive ability in humans, mice and flies - The study finds a greater presence of these viruses in people who eat dairy products in their regular diet

Study in Spain and Romania confirms radon as second leading cause of lung cancer

Xenomics Names Research Oncologist and Biotechnology Executive Dr. David Sidransky to Board of Directors

Sartorius closes acquisition of selected assets of Danaher Life Sciences - Broadens portfolio for the development and production of biotech medicines

Sartorius closes acquisition of selected assets of Danaher Life Sciences - Broadens portfolio for the development and production of biotech medicines

EMA starts rolling review of COVID-19 vaccine Vidprevtyn - Protein-based vaccine developed by Sanofi Pasteur

EMA starts rolling review of COVID-19 vaccine Vidprevtyn - Protein-based vaccine developed by Sanofi Pasteur

Researchers use sugar to halt esophageal cancer in its tracks

Anika Therapeutics Announces Termination of Worldwide Development and Commercialization Partnership with OrthoNeutrogena - Company Files Pre-Market Approval Applicaton for Cosmetic Tissue Augmentation Product